📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discovery of CVN417, a Novel Brain-Penetrant a6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction. (2023)

First Author: Christie LA

Attributed to: Defining the striatal dopamine signals that enable movement: a high resolution spatiotemporal characterisation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.3c00630

PubMed Identifier: 37651656

Publication URI: http://europepmc.org/abstract/MED/37651656

Type: Journal Article/Review

Volume: 66

Parent Publication: Journal of medicinal chemistry

Issue: 17

ISSN: 0022-2623